NL-OMON40908撤回4 期
Bioavailability of voriconazole in critically ill patients - Bioavailability of voriconazole
适应症
试验速览
- 阶段
- 4 期
- 状态
- 撤回
- 入组人数
- 13
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Aged * 18 yrs;
- •Treatment with voriconazole;
- •Admission to an ICU;
- •Written informed consent.
排除标准
- •Blood sampling by central venous catheter or peripheral cannula not possible;
- •Concomitantly using a strong inhibitor or inducer of cytochrome P450.
研究者
相似试验
进行中（未招募）
不适用
Study of the bioavailability of voriconazole in intensive care patientsSuspected or prophylaxis of invasive aspergillosis.EUCTR2014-001222-15-NLniversity Medical Center Groningen
撤回
4 期
Bioavailability of VoriconazoleVoriconazoleBioavailabilityCritically IllNCT02110316University Medical Center Groningen
已完成
不适用
Bioavailability and Metabolism of Voriconazole in Relation to Its Modulation by the CYP2C19 Genetic PolymorphismHealthyNCT00175994Heidelberg University24
进行中（未招募）
1 期
Study of the effectiveness of Voriconazole in the treatment of Aspergillus fumigatus associated asthma - Effectiveness of Voriconazole in Aspergillus associated asthmaAsthma with sensitization to aspergillus and isolation in sputum.EUCTR2009-011452-21-GBniversity Hospitals of Leicester NHS trust
已完成
不适用
Study of the effectiveness of voriconazole in the treatment of Aspergillus fumigatus associated asthmaAsthmaRespiratoryISRCTN42366088niversity Hospitals of Leicester NHS Trust (UK)70